|1.||Merino, G: 2 articles (01/2015 - 08/2011)|
|2.||Barrera, B: 2 articles (01/2015 - 08/2011)|
|3.||Prieto, J G: 2 articles (01/2015 - 08/2011)|
|4.||Rowan, T G: 2 articles (06/2007 - 10/2006)|
|5.||Rowan, Tim G: 2 articles (12/2006 - 09/2002)|
|6.||Ayling, R D: 2 articles (10/2006 - 02/2000)|
|7.||Shostrom, Valerie K: 2 articles (02/2005 - 05/2004)|
|8.||Skogerboe, Terry L: 2 articles (02/2005 - 05/2004)|
|9.||Lees, P: 2 articles (02/2003 - 12/2001)|
|10.||Ruiz-Palomero, Celia: 1 article (05/2015)|
08/01/2003 - "To evaluate an experimental model of the pharmacokinetic/pharmacodynamic (PK/PD) relationship of danofloxacin against Mannheimia haemolytica infection, using subcutaneously implanted tissue cages in calves. "
06/01/2003 - "Twenty hours after experimental infection, the 18 pigs received danofloxacin intravenously as a single dose of 2.5mg/kg or four doses of 0.6 mg/kg administered at 24h intervals. "
06/01/2003 - "Evaluation of a single dose versus a divided dose regimen of danofloxacin in treatment of Actinobacillus pleuropneumoniae infection in pigs."
04/01/2009 - "The reported results support the potential use of danofloxacin in the treatment of mastitis and other infections in milk cows with 3 days of withdrawal."
04/01/1993 - "Danofloxacin was highly efficacious in controlling this infection in all three experiments, whereas tylosin was efficacious in only one. "
|2.||Bacterial Infections (Bacterial Infection)
12/22/2008 - "Danofloxacin shows a favourable pharmacokinetic profile in loggerhead turtles reflected by parameters such as a long half-life and a high bioavailability following a single dose of 6 mg kg(-1) by IM and SC routes; thus, it is likely that this treatment will be effective in loggerhead turtles with bacterial infections."
07/01/2006 - "administration of danofloxacin in horses indicates that it is likely to be effective for treating sensitive bacterial infections."
03/01/2013 - "Because of their more favorable pharmacokinetic properties after oral administration, either danofloxacin or marbofloxacin appears to be preferable to enrofloxacin for the treatment of susceptible bacterial infection in Japanese quail."
12/01/1990 - "The efficacy of danofloxacin, a novel third generation fluoroquinolone, was assessed in the treatment of pneumonia in housed calves on three farms in the FDR and Italy. "
12/01/1990 - "The efficacy of danofloxacin in the therapy of pneumonia associated with Pasteurella species in housed calves."
06/01/1993 - "Plasma and lung tissue pharmacokinetics of danofloxacin in calves with naturally induced acute pneumonia were determined in 2 separate studies. "
09/01/2002 - "The pharmacokinetics and pharmacodynamics of danofloxacin in calves with induced Mannheimia (Pasteurella) haemolytica pneumonia were evaluated. "
06/01/1993 - "Our findings indicated that a large percentage of danofloxacin is rapidly absorbed after IM administration to calves with acute pneumonia. "
10/01/2006 - "The efficacy of danofloxacin (Advocin A180) was evaluated for the treatment of contagious caprine pleuropneumonia (CCPP) caused by Mycoplasma capricolum subsp. "
12/01/2006 - "Danofloxacin (Advocin) reduces the spread of contagious bovine pleuropneumonia to healthy in-contact cattle."
10/01/2006 - "Effect of danofloxacin (Advocin A180) on goats affected with contagious caprine pleuropneumonia."
02/26/2000 - "Minimum inhibitory concentrations (MIC) and minimum mycoplasmacidal concentrations (MMC) of the antimicrobials danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin were determined in vitro for 20 isolates of Mycoplasma mycoides subspecies mycoides small colony type (MmmSC), the causative agent of contagious bovine pleuropneumonia (CBPP). "
|5.||Pneumonic Pasteurellosis (Shipping Fever)
06/02/2007 - "Efficacy of danofloxacin in the treatment of pneumonic pasteurellosis in specific pathogen-free lambs."
02/01/2005 - "When used to treat pneumonic pasteurellosis in calves, danofloxacin and enrofloxacin can be expected to deliver concentration-dependent bactericidal activity against M. "
|8.||Penicillin G (Benzylpenicillin)
|9.||Anti-Bacterial Agents (Antibiotics)